Ignite Creation Date:
2024-07-17 @ 10:42 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06475235
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-06-20
Brief Title:
Pembrolizumab Chemotherapy in Newly Diagnosed PCNSL
Sponsor:
Organization:
Dana-Farber Cancer Institute